DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Extension Study Evaluating Etanercept in Ankylosing Spondylitis

Information source: Wyeth
Information obtained from ClinicalTrials.gov on February 12, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Ankylosing Spondylitis

Intervention: Enbrel (etanercept) (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Wyeth

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth Reserach

Overall contact:
Trial Manager, Email: clintrialparticipation@wyeth.com

Summary

The primary purpose of this study is to evaluate the health care resource utilization and work status of patients with ankylosing spondylitis undergoing treatment with etanercept by comparing study evaluations with the baseline evaluations in the ASCEND (0881A3-402-WW)study.

Clinical Details

Official title: An Open-Label, Multicentre, Supplementary Extension Study of Etanercept in Subjects With Ankylosing Spondylitis

Study design: Treatment, Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study

Primary outcome: Health Economics Outcomes: assessment of quality of life and health care resource utilization and work status

Secondary outcome:

Evaluate health care utilization

Assess the new "Haywood" quality of life instrument

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion criteria:

- Patients who completed 16 weeks of treatment and have completed the baseline health

care resource utilization questionnaire at screening in the ASCEND study 0881A3-402-WW from participating countries.

Exclusion criteria:

- Withdrawal from the ASCEND study for safety or any other reason.

Locations and Contacts

Trial Manager, Email: clintrialparticipation@wyeth.com

Fredriksberg DK-2000, Denmark; Recruiting

Vejle DK-7100, Denmark; Recruiting

Odense DK-5000, Denmark; Recruiting

Svendborg DK-5700, Denmark; Recruiting

Helsinki FIN-130, Finland; Recruiting

Kuopio FIN-70211, Finland; Active, not recruiting

Tampere FIN-33100, Finland; Recruiting

Hyvinkaa FIN-05800, Finland; Recruiting

Stockholm SE-17176, Sweden; Recruiting

Newcastle upon Tyne NE77DN, United Kingdom; Recruiting

Wirral CH495PE, United Kingdom; Recruiting

Cambridge CB22QQ, United Kingdom; Recruiting

Bath BA11RL, United Kingdom; Recruiting

Cannock WS112XY, United Kingdom; Recruiting

Liverpool L97AL, United Kingdom; Recruiting

Basingstoke RG249NA, United Kingdom; Recruiting

Additional Information

Starting date: December 2006
Ending date: September 2008
Last updated: December 21, 2007

Page last updated: February 12, 2009

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012